https://edge.media-server.com/mmc/p/dach99xb
Prime Medicine And Cimeio Therapeutics Announce Research Collaboration To Develop Prime Edited Shielded-Cell & Immunotherapy Pairs For Genetic Diseases, Acute Myeloid Leukemia And Myelodysplastic Syndrome
-- Collaboration combines Prime Medicine's Prime Editing platform with Cimeio Therapeutics' Shielded Cell and Immunotherapy Pairs™ (SCIP™) platform --
-- Aim to reduce toxicity of conditioning
